Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.

Vol.22 No.4

Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.

Takao Nagashima¹ , Hitoaki Okazaki¹ , Yasuyuki Kamata¹ , Seiji Minota¹

Division of Rheumatology and Clinical Immunology, Jichi Medical University, Yakushiji 3311-1, Shimotsuke, Tochigi, 329-0498, Japan

9 August 2011

31 August 2011

7 June 2012

PDF　(member's only)

Without Abstract

Glucocorticoid - Matrix metalloproteinase-3 - Rheumatoid arthritis